Measles, mumps, rubella vaccine

Notes Measles, mumps and rubella vaccines are generally administered in the form of a combined measles/mumps/rubella vaccine (MMR vaccine). 

MMR measles mumps rubella MMRV measles-mumps-rubella vaccine... 

Wakefield AJ, Montgomery SM. Measles, mumps, rubella vaccine through a glass, darkly. Adverse Drug React Toxicol Rev 2000 19(4) 265-83. 

Immunization Safety Review Committee. Immunization safety review measles-mumps-rubella vaccine and autism. In Stratton K, Gable A, Shetty P, McCormick M, editors. Institute of MedicineNational Academy of Sciences, 2001 241. 

Halsey NA, Hyman SLConference Writing Panel. Measles-mumps-rubella vaccine and autistic spectrum disorder report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook. Illinois, June 12-13, 2000Pediatrics 2001 107(5) E84. 

Table 2 Clinical effects of acute encephalopathy in 48 patients 2-15 days after the first dose of measles, measles-measles-mumps-rubella vaccine, and sequelae, 1970-93 -rubella, or...

Black S, Shinefield H, Ray P, Lewis E, Chen R, Glasser J, Hadler S, Hardy J, Rhodes P, Swint E, Davis R, Thompson R, Mullooly J, Marcy M, Vadheim C, Ward J, Rastogi S, Wise R. Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children an analysis of the Vaccine Safety Datalink (VSD) Project. Pediatr Infect Dis J 1997 16(5) 500-3. 

Dourado 1, Cunha S, Teixerra MG, Farrington CP, Melo A, Lucena R, Barreto ML. Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine implications for immunization programs. Am J Epidemiol 2000 151(5) 524-30. 

McCormick A, Dinakaran S, Bhola R, Rennie IG. Recurrent sixth nerve palsy following measles mumps rubella vaccination. Eye 2001 15(Pt 3) 356-7. 

Patja A, Paunio M, Kinnunen E, Junttila O, Hovi T, Peltola H. Risk of Guillain-Barre syndrome after measles-mumps-rubella vaccination. J Pediatr 2001 138(2) 250-4. 

Vlacha V, Forman EN, Miron D, Peter G. Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination. Pediatrics 1996 97(5) 738-9. 

Rollan AR, Pool V, Chen R, Rhodes P. Indications for measles-mumps-rubella vaccination in a child with prior thrombocytopenia purpura. Pediatr Infect Dis J 1997 I6(4) 423-4. 

DeStefano F, Chen RT. Autism and measles-mumps-rubella vaccination. Controversy laid to rest CNSDrugs 2001 15(11) 831 7. 

King GE, Markowitz LE, Heath J, et al. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination. JAMA 1996 275 704-707. 

Measles, Mumps, Rubella vaccination (MMR)—Measles component Adults born before 1957 may be considered immune to measles. Adults born in or after 1957 should receive at least one dose of MMR unless they have a medical contraindication, documentation of at least one dose or other acceptable evidence of immunity. A second... 

Matrix-assisted laser desorption ionization time of flight, see MALDI-TOF Matrix-assisted laser desorption ionization time of flight mass spectrometry, see MALDI-TOF-MS Maximum plasma concentration 51 Maytansanoids, cytotoxic 1172 MCFD2 427 MDRl 58 Meal insulin 1454 Measles-mumps-rubella vaccine 1421 Mecasermin 465... 

Patja A, Davidkin I, Kurki T, KalUo MJ, VaUe M, Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective foUow-up. Pediatr Infect Dis J 2000 19(12) 1127-1134. 

Patja A, Makinen-Kiljunen S, Davidkin I, Paunio M, Peltola H. AUergic reactions to measles-mumps-rubella vaccination. Pediatrics 2001 107(2) E27. 

Pool V, Braun MM, Kelso JM, Mootrey G, Chen RT, Yunginger JW, Jacobson RM, Gargiullo PM, VAERS Team. US Vaccine Adverse Event Reporting System. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States. Pediatrics 2002 110(6) e71. 

Mantadakis E, Farmaki E, Buchanan GR. Thrombocytopenic purpura after measles-mumps-rubella vaccination a systematic review of the literature and guidance for management. J Pediatr 2010 156 623-8. 

Zanoni G, Puccetti A, Dolcino M, Simone R, Peretti A, Ferro A, Tridente G. Dextran-specific IgG response in hypersensitivity reactions to measles-mumps-rubella vaccine. J Allergy Clin Immunol 2008 122(6) 1233-5. 

---